Myriad Genetics News
Most Popular Myriad Genetics Story
Lilly readies Phase III Alzheimer's trial
Struggling to right itself after a long dry spell in new drug approvals, Eli Lilly is preparing to a launch a late-stage study of an experimental drug for Alzheimer's. LY450139 is expected to inhibit... Read more...
Latest Headlines
- April 19, 2010
- March 31, 2010
- February 5, 2010
- December 18, 2009
- January 21, 2009
- December 19, 2008
- October 21, 2008
- September 11, 2008
- August 20, 2008
- June 30, 2008
- May 30, 2008
- March 31, 2008
- January 7, 2007
- July 17, 2006
- April 12, 2006
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
